2024澳门原料网网站官网-免费完整资料
ENG
中文
ENG
Home
About Langhua
About Langhua
ABOUT LANGHUA
More
About Us
Enterprise Showcase
Management Team
Solution & Service
Solution & Service
More
API & Intermediates CDMO Service
Process Development Service
Synthesis Route Design
Development & Optimization
QbD Study
Process Validation
Manufacturing Service
Process Development Service
Drug Product CDMO Service
Pre-clinical Drug Product R&D Service
Salt and Polymorph Screening
NCE Characterization
Pre Clinical Formulation Development
Clinical Drug Product R&D Services
Clinical and Commercial Drug Product Manufacturing Services
Global Regulatory Submission Services
Analytical Service
API Analysis Service
Pre-formulation Analysis Service
Drug Product Analysis Service
Stability Study
Data Integrity
Support
Global CMC Filing
Project Management
Product Lifecycle Management
Technology Platform
Technology Platform
More
APIs Technology Platform
Drug Product Platform Technology
Product Center
Product Center
More
Product Catalogue
Compliance
Compliance
More
GMP System
EHS System
IP Protection
News
News
More
Company News
Recent Events
Group News
Career
Career
More
Talent Concept
Development and Training
Salary and Welfare
Social Recruitment
Campus Recruitment
Join Us
Contact Us
ENG
中文
ENG
Home
About Langhua
About Us
Enterprise Showcase
Management Team
Solution & Service
API & Intermediates CDMO Service
Process Development Service
Manufacturing Service
Process Safety Assessment Service
Drug Product CDMO Service
Pre-clinical Drug Product R&D Service
Clinical Drug Product R&D Services
Clinical and Commercial Drug Product Manufacturing Services
Global Regulatory Submission Services
Analytical Service
APl Analysis Service
Pre-formulation Analysis Service
Drug Product Analysis Service
Stability Study
Data Integrity
Support
Global CMC Filing
Project Management
Product Lifecycle Management
Technology Platform
APIs Technology Platform
Green Chemistry Technology Platform
Drug Milling/Micronization Technology
Drug Product Platform Technology
Pediatric Dosage Forms
Oral Dosage Forms
Topical Dosage Forms
Liquid Dosage Form Platform
Poorly Soluble Drug Solubilization Technology Platform
Preclinical Animal Formulation Development and Their In Vitro and In Vivo Evaluation
Salt and Polymorph Screening
Physicochemical and Biopharmaceutical Characterization of Medicinal Compounds/Drug Substances
Product Center
Compliance
GMP System
EHS System
IP Protection
News
Career
Contact Us
News Center
News
About Langhua
Solution & Service
Technology Platform
Product Center
Compliance
News
Career
Group News
Company News
Recent Events
Group News
Unifying strength towards future: Viva Biotech's 2023 Milestone
2024.01.02
[Abstract]:Farewell 2023, Meet 2024 - Together we head towards the next journey
Previous Page:
Viva Biotech was honored with
Next Page:
Viva Insights: Using a Biophysical Technology Platform Makes Drug Development Faster and Optimizes Success
Back
News
Company News
Recent Events
Group News
News Recommendations
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future
2024-03-28
Viva Biotech and Lonza Enter Licensing Agreement for Lonza's bYlok® Bispecific Pairing Technology
2024-03-20